Use of noninvasive fibrosis calculators in an urban diabetes center suggests a large burden of undetected advanced liver disease
Ahmed Ebeid,
Fatma Mokhtar,
Valeria Martinez-Lebron
et al.
Abstract:Background
Metabolic dysfunction associated steatotic liver disease (MASLD) is prevalent in up to 60% of patients with type 2 diabetes mellitus (T2DM). T2DM accelerates the risk of hepatic fibrosis and hepatocellular carcinoma in patients with MASLD. Our goal in this study was to identify patients with suspected MASLD and hepatic fibrosis in a large T2DM clinic by using noninvasive fibrosis scoring systems.
Methods
We conducted a retrospective study of patients with T2DM seen by our endocrinologists at the M… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.